Layer, Chiang, et al. Genome Biology
InteRNA Inks Sponsored-Research Deal with Dana Farber for miRNA Cancer Rx Discovery
Under the deal, InteRNA’s lentiviral-based miRNA over-expression library will be used in “multi-parametric, high-throughput functional screening assays” to identify the role of individual miRNAs in various cancer pathways. The company hopes to discover novel miRNAs as therapeutic targets.
New to GenomeWeb? Register here quickly.